Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Treasury Shares (2023 - 2025)

Historic Treasury Shares for Camp4 Therapeutics (CAMP) over the last 3 years, with Q1 2025 value amounting to $4277.0.

  • Camp4 Therapeutics' Treasury Shares changed N/A to $4277.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $4277.0, marking a year-over-year change of. This contributed to the annual value of $15943.0 for FY2024, which is 7852.59% down from last year.
  • As of Q1 2025, Camp4 Therapeutics' Treasury Shares stood at $4277.0.
  • Camp4 Therapeutics' Treasury Shares' 5-year high stood at $74243.0 during Q4 2023, with a 5-year trough of $4277.0 in Q1 2025.
  • Moreover, its 3-year median value for Treasury Shares was $23275.0 (2024), whereas its average is $31267.5.
  • Within the past 5 years, the most significant YoY rise in Camp4 Therapeutics' Treasury Shares was 7852.59% (2024), while the steepest drop was 7852.59% (2024).
  • Quarter analysis of 3 years shows Camp4 Therapeutics' Treasury Shares stood at $74243.0 in 2023, then plummeted by 78.53% to $15943.0 in 2024, then tumbled by 73.17% to $4277.0 in 2025.
  • Its Treasury Shares was $4277.0 in Q1 2025, compared to $15943.0 in Q4 2024 and $30607.0 in Q3 2024.